Close
ACHEMA MIDDLE EAST 2026

Factors Influencing Current APAC Biopharma & Healthcare

In the last five years, there have been various local governments in the Asia-Pacific region that have enacted beneficial policies and also regulatory frameworks...

Innovation-First Mindset: Key To Drive Advanced Therapies

The Advanced Therapies Treatment Centre- ATTC Network has gone on to release a report that stresses the pressing need when it comes to swift...

2024 May See Pharma, Life Sciences Have Sound M&A Activity

In all probabilities, it is expected that mergers & acquisitions in the pharma and life sciences sectors will hit a healthy level in 2024,...

Temp Resistant Pharma Packaging To Hit 945.2mn By 2030

In 2022, the global market for pharmaceutical temperature-controlled packaging solutions happened to be valued at USD 578.9 million. It is, in all probabilities, set...

Advances making way for 2024 Cold Chain Packaging Solutions

As per the recent projections, the market when it comes to temperature-controlled packaging solutions is most likely to reach almost $26.2 billion by 2030,...

10 Benefits of Digital Transformation In Pharma Production

In the healthcare industry, both patients as well as caregivers share a common desire for the best possible outcome. Technology makes it much easier...

Pharma Sector And Technology Trends To Watch Out For In 2024

It is well worth noting that the last few years have seen a rapid period when it comes to technological adoption in the life...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...